SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+1.72%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$252M
AUM Growth
+$252M
(-6.9%)
Cap. Flow
-$23.7M
Cap. Flow
% of AUM
-9.38%
Top 10 Holdings %
Top 10 Hldgs %
29.07%
Holding
74
New
14
Increased
11
Reduced
28
Closed
13
Top Buys
| 1 |
Becton Dickinson
BDX
|
$8.19M |
| 2 |
UnitedHealth
UNH
|
$7.32M |
| 3 |
Pfizer
PFE
|
$6.5M |
| 4 |
Tenet Healthcare
THC
|
$3.51M |
| 5 |
Neurocrine Biosciences
NBIX
|
$3.38M |
Top Sells
| 1 |
Novo Nordisk
NVO
|
$7.06M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$6.08M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$4.28M |
| 4 |
Viatris
VTRS
|
$4.25M |
| 5 |
Biogen
BIIB
|
$3.55M |
Sector Composition
| 1 | Healthcare | 95.16% |
| 2 | Energy | 1.18% |
| 3 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Humana
HUM
$36.5B
| $8.62M | 2.08% |
32,500
+2,500
| +8% | +$663K |
|
2
Boston Scientific
BSX
$156B
| $8.6M | 2.08% |
200,000
-25,000
| -11% | -$1.07M |
|
|
3
Becton Dickinson
BDX
$55.3B
| $8.19M | 1.98% |
+32,500
| New | +$8.19M |
|
|
4
UnitedHealth
UNH
$281B
| $7.32M | 1.77% |
+30,000
| New | +$7.32M |
|
5
Danaher
DHR
$147B
| $7.15M | 1.73% |
50,000
-10,000
| -17% | -$1.43M |
|
6
Elevance Health
ELV
$71.8B
| $7.06M | 1.71% |
25,000
-2,500
| -9% | -$706K |
|
7
Baxter International
BAX
$12.7B
| $6.96M | 1.68% |
85,000
-20,000
| -19% | -$1.64M |
|
8
Abbott
ABT
$231B
| $6.73M | 1.63% |
80,000
-20,000
| -20% | -$1.68M |
|
|
9
Pfizer
PFE
$141B
| $6.5M | 1.57% |
+150,000
| New | +$6.5M |
|
10
Regeneron Pharmaceuticals
REGN
$61.5B
| $6.26M | 1.51% |
20,000
+7,000
| +54% | +$2.19M |
|
11
Eli Lilly
LLY
$657B
| $6.09M | 1.47% |
55,000
-15,000
| -21% | -$1.66M |
|
12
Labcorp
LH
$23.1B
| $6.05M | 1.46% |
35,000
+10,000
| +40% | +$1.73M |
|
13
Merck
MRK
$210B
| $5.87M | 1.42% |
70,000
-25,000
| -26% | -$2.1M |
|
14
Edwards Lifesciences
EW
$47.8B
| $5.73M | 1.38% |
31,000
+15,000
| +94% | +$2.77M |
|
15
Molina Healthcare
MOH
$9.8B
| $5.73M | 1.38% |
40,000
-15,000
| -27% | -$2.15M |
|
|
WCG
16
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.7M | 1.38% |
20,000
-15,000
| -43% | -$4.28M |
|
|
CELG
17
DELISTED
Celgene Corp
CELG
| $5.55M | 1.34% |
60,000
| – | – |
|
18
Vertex Pharmaceuticals
VRTX
$100B
| $5.5M | 1.33% |
30,000
| – | – |
|
19
Bio-Rad Laboratories Class A
BIO
$8.06B
| $5.47M | 1.32% |
17,500
-2,500
| -13% | -$781K |
|
20
HCA Healthcare
HCA
$94.5B
| $5.41M | 1.31% |
40,000
-20,000
| -33% | -$2.7M |
|
21
Universal Health Services
UHS
$11.6B
| $5.22M | 1.26% |
40,000
-5,000
| -11% | -$652K |
|
22
Elanco Animal Health
ELAN
$9.12B
| $5.07M | 1.23% |
150,000
-25,000
| -14% | -$845K |
|
|
WMGI
23
DELISTED
Wright Medical Group Inc
WMGI
| $4.77M | 1.15% |
160,000
| – | – |
|
24
Thermo Fisher Scientific
TMO
$186B
| $4.41M | 1.07% |
15,000
-5,000
| -25% | -$1.47M |
|
25
Smith & Nephew
SNN
$16.3B
| $4.35M | 1.05% |
100,000
-10,000
| -9% | -$435K |
|